- Issuer ticker
-
APLS
- Reported as of
-
28 Jan 2022
- Net transaction value
-
-$72,208
- SEC form
-
4
- Accepted by SEC
-
01 Feb 2022, 16:58:09 UTC
Filing notes and source
Key filing fact
Lukas Scheibler filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 01 Feb 2022.
Key facts
- This page summarizes Lukas Scheibler's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Feb 2022, 16:58.
Change
- Previous filing in this sequence was filed on 24 Jan 2022.
- Current net transaction value: -$72,208.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Tax liability
- Transaction value
- -$24,775
- Shares
- -642
- Change %
- -1.2%
- Price
-
$38.59
- Shares after
- 55,090
- Date
- 28 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
APLS
transaction
Common Stock
Sale
- Transaction value
- -$47,434
- Shares
- -1,233
- Change %
- -2.2%
- Price
-
$38.47
- Shares after
- 53,857
- Date
- 31 Jan 2022
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes